Reviewed,
UniProtKB/Swiss-Prot P13637 (AT1A3_HUMAN)
Last modified
November 24, 2009.
Version 115.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Sodium/potassium-transporting ATPase subunit alpha-3 Short name=Sodium pump subunit alpha-3 EC=3.6.3.9 Alternative name(s): Na(+)/K(+) ATPase alpha-3 subunit Na(+)/K(+) ATPase alpha(III) subunit | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1013 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. |
| Catalytic activity | ATP + H2O + Na+(In) + K+(Out) = ADP + phosphate + Na+(Out) + K+(In). |
| Subunit structure | Composed of three subunits: alpha (catalytic), beta and gamma. |
| Subcellular location | |
| Involvement in disease | Defects in ATP1A3 are the cause of dystonia type 12 (DYT12) [MIM:128235]; also known as rapid-onset dystonia parkinsonism (RDP). DYT12 is an autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. Ref.8 |
| Sequence similarities | Belongs to the cation transport ATPase (P-type) family. Type IIC subfamily. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1013 | 1013 | Sodium/potassium-transporting ATPase subunit alpha-3 | PRO_0000046298 | |||||
Regions | |||||||||
| Topological domain | 1 – 77 | 77 | Cytoplasmic Potential | ||||||
| Transmembrane | 78 – 98 | 21 | Potential | ||||||
| Topological domain | 99 – 121 | 23 | Lumenal Potential | ||||||
| Transmembrane | 122 – 142 | 21 | Potential | ||||||
| Topological domain | 143 – 278 | 136 | Cytoplasmic Potential | ||||||
| Transmembrane | 279 – 298 | 20 | Potential | ||||||
| Topological domain | 299 – 310 | 12 | Lumenal Potential | ||||||
| Transmembrane | 311 – 328 | 18 | Potential | ||||||
| Topological domain | 329 – 762 | 434 | Cytoplasmic Potential | ||||||
| Transmembrane | 763 – 782 | 20 | Potential | ||||||
| Topological domain | 783 – 792 | 10 | Lumenal Potential | ||||||
| Transmembrane | 793 – 813 | 21 | Potential | ||||||
| Topological domain | 814 – 833 | 20 | Cytoplasmic Potential | ||||||
| Transmembrane | 834 – 856 | 23 | Potential | ||||||
| Topological domain | 857 – 908 | 52 | Lumenal Potential | ||||||
| Transmembrane | 909 – 928 | 20 | Potential | ||||||
| Topological domain | 929 – 941 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 942 – 960 | 19 | Potential | ||||||
| Topological domain | 961 – 975 | 15 | Lumenal Potential | ||||||
| Transmembrane | 976 – 996 | 21 | Potential | ||||||
| Topological domain | 997 – 1013 | 17 | Cytoplasmic Potential | ||||||
| Region | 72 – 74 | 3 | Interaction with phosphoinositide-3 kinase By similarity | ||||||
Sites | |||||||||
| Active site | 366 | 1 | 4-aspartylphosphate intermediate By similarity | ||||||
| Metal binding | 707 | 1 | Magnesium By similarity | ||||||
| Metal binding | 711 | 1 | Magnesium By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 265 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 368 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 493 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 548 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 549 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 933 | 1 | Phosphoserine; by PKA By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 274 | 1 | I → T in DYT12. Ref.8 | VAR_026735 | |||||
| Natural variant | 277 | 1 | E → K in DYT12. Ref.8 | VAR_026736 | |||||
| Natural variant | 613 | 1 | T → M in DYT12. Ref.8 | VAR_026737 | |||||
| Natural variant | 758 | 1 | I → S in DYT12. Ref.8 | VAR_026738 | |||||
| Natural variant | 780 | 1 | F → L in DYT12. Ref.8 | VAR_026739 | |||||
| Natural variant | 801 | 1 | D → Y in DYT12. Ref.8 | VAR_026740 | |||||
Experimental info | |||||||||
| Sequence conflict | 1 – 2 | 2 | MG → MEIH Ref.2 | ||||||
| Sequence conflict | 336 | 1 | L → V Ref.1 | ||||||
| Sequence conflict | 336 | 1 | L → V Ref.2 | ||||||
| Sequence conflict | 336 | 1 | L → V Ref.4 | ||||||
| Sequence conflict | 336 | 1 | L → V Ref.6 | ||||||
| Sequence conflict | 380 | 1 | H → T in AAA52285. Ref.4 | ||||||
| Sequence conflict | 421 | 1 | A → P Ref.6 | ||||||
| Sequence conflict | 430 | 1 | I → M in CAA31390. Ref.2 | ||||||
| Sequence conflict | 555 – 557 | 3 | FPK → YPQ Ref.1 | ||||||
| Sequence conflict | 555 – 557 | 3 | FPK → YPQ Ref.2 | ||||||
| Sequence conflict | 555 – 557 | 3 | FPK → YPQ in AAA52286. Ref.4 | ||||||
| Sequence conflict | 577 | 1 | G → P in AAA51798. Ref.1 | ||||||
| Sequence conflict | 583 | 1 | D → G Ref.1 | ||||||
| Sequence conflict | 583 | 1 | D → G Ref.2 | ||||||
| Sequence conflict | 583 | 1 | D → G in AAA52286. Ref.4 | ||||||
| Sequence conflict | 919 | 1 | V → A in AAA52286. Ref.4 | ||||||
| Sequence conflict | 944 | 1 | L → M in AAA52286. Ref.4 | ||||||
| Sequence conflict | 982 | 1 | F → S in CAA31390. Ref.2 | ||||||
| Sequence conflict | 1006 | 1 | W → S in AAA51798. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
Cross-references
Sequence databases | |
|---|---|
M37457 M37456 Genomic DNA. Translation: AAA51798.1. X12910 X12923 Genomic DNA. Translation: CAA31390.1. BC009282 mRNA. Translation: AAH09282.1. BC009394 mRNA. Translation: AAH09394.1. BC015566 mRNA. Translation: AAH15566.1. M28286, M28284, M28285 Genomic DNA. Translation: AAA52285.1. M28293 M28292 Genomic DNA. Translation: AAA52286.1. M27577, M27570, M27573 Genomic DNA. Translation: AAA58380.1. | |
| IPI | IPI00302840. |
| PIR | S00801. |
| RefSeq | NP_689509.1. |
| UniGene | Hs.515427 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P13637. 1 interaction. |
| STRING | P13637. |
PTM databases | |
| PhosphoSite | P13637. |
Proteomic databases | |
| PRIDE | P13637. |
Genome annotation databases | |
| Ensembl | ENST00000302102; ENSP00000302397; ENSG00000105409; Homo sapiens. [Genome view] |
| GeneID | 478. |
| KEGG | hsa:478. |
| UCSC | uc002osg.1. human. |
Organism-specific databases | |
| CTD | 478. |
| GeneCards | GC19M047162. |
| HGNC | HGNC:801. ATP1A3. |
| MIM | 128235. phenotype. 182350. gene. |
| Orphanet | 71517. Rapid-onset dystonia-parkinsonism. |
| PharmGKB | PA64. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | P13637. |
| HOVERGEN | P13637. |
| OrthoDB | EOG9THZCP |
Enzyme and pathway databases | |
| BRENDA | 3.6.3.9. 247. |
Gene expression databases | |
| ArrayExpress | P13637. |
| Bgee | P13637. |
| CleanEx | HS_ATP1A3. |
| Genevestigator | P13637. |
| GermOnline | ENSG00000105409. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008250. ATPase_P-typ_ATPase-assoc-reg. IPR005775. ATPase_P-typ_cation-ex_asu_euk. IPR006069. ATPase_P-typ_cation-exchng_asu. IPR006068. ATPase_P-typ_cation-transptr_C. IPR004014. ATPase_P-typ_cation-transptr_N. IPR001757. ATPase_P-typ_ion-transptr. IPR018303. ATPase_P-typ_P_site. IPR005834. Dehalogen-like_hydro. [Graphical view] |
| PANTHER | PTHR11939. ATPase_P. 1 hit. |
| Pfam | PF00689. Cation_ATPase_C. 1 hit. PF00690. Cation_ATPase_N. 1 hit. PF00122. E1-E2_ATPase. 1 hit. PF00702. Hydrolase. 1 hit. [Graphical view] |
| PRINTS | PR00119. CATATPASE. PR00121. NAKATPASE. |
| SMART | SM00831. Cation_ATPase_N. 1 hit. [Graphical view] |
| TIGRFAMs | TIGR01106. ATPase-IIC_X-K. 1 hit. TIGR01494. ATPase_P-type. 4 hits. |
| PROSITE | PS00154. ATPASE_E1_E2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 1981. |
| SOURCE | Search... |
Entry information
| Entry name | AT1A3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P13637 Secondary accession number(s): Q16732, Q16735, Q969K5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


